Wooridul Huebrain Limited (118000.KS)
KRW 327.0
(-4.11%)
KRW 327.0
(-4.11%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -138.00 KRW | 85.94% |
| 2022 | -979.81 KRW | -927.82% |
| 2021 | 118.36 KRW | -50.35% |
| 2020 | 238.41 KRW | 263.45% |
| 2019 | -145.86 KRW | 68.76% |
| 2018 | -466.89 KRW | -262.15% |
| 2017 | -128.92 KRW | 70.37% |
| 2016 | -435.08 KRW | 28.23% |
| 2015 | -606.24 KRW | 17.53% |
| 2014 | -735.06 KRW | 80.44% |
| 2013 | -3757.53 KRW | -587.95% |
| 2012 | -546.19 KRW | 69.6% |
| 2011 | -1796.54 KRW | -333.34% |
| 2010 | -414.58 KRW | -887.58% |
| 2009 | 52.64 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 95.30 KRW | 223.4% |
| 2024 Q2 | -12.05 KRW | -112.59% |
| 2023 FY | - KRW | 85.94% |
| 2023 Q2 | 34.23 KRW | 259.8% |
| 2023 Q1 | -21.42 KRW | 92.88% |
| 2023 Q4 | -77.23 KRW | -55.83% |
| 2023 Q3 | -49.56 KRW | -244.79% |
| 2022 FY | - KRW | -927.82% |
| 2022 Q2 | -187.21 KRW | -162.31% |
| 2022 Q1 | -71.37 KRW | -3037.04% |
| 2022 Q3 | -121.05 KRW | 35.34% |
| 2022 Q4 | -301.02 KRW | -148.67% |
| 2021 Q3 | -57.30 KRW | -129.38% |
| 2021 Q1 | -59.52 KRW | -145.48% |
| 2021 FY | - KRW | -50.35% |
| 2021 Q2 | 195.00 KRW | 427.62% |
| 2021 Q4 | 2.43 KRW | 104.24% |
| 2020 Q4 | 130.87 KRW | 99.25% |
| 2020 Q2 | 84.32 KRW | 286.22% |
| 2020 Q1 | -45.28 KRW | -249.39% |
| 2020 FY | - KRW | 263.45% |
| 2020 Q3 | 65.68 KRW | -22.11% |
| 2019 Q1 | -79.00 KRW | 69.41% |
| 2019 FY | - KRW | 68.76% |
| 2019 Q3 | -59.47 KRW | 12.99% |
| 2019 Q4 | 30.31 KRW | 150.97% |
| 2019 Q2 | -68.35 KRW | 13.48% |
| 2018 Q1 | -71.01 KRW | -434.64% |
| 2018 Q4 | -258.24 KRW | -334.24% |
| 2018 Q3 | -59.47 KRW | 28.73% |
| 2018 FY | - KRW | -262.15% |
| 2018 Q2 | -83.44 KRW | -17.5% |
| 2017 FY | - KRW | 70.37% |
| 2017 Q2 | -107.40 KRW | -128.32% |
| 2017 Q3 | -100.30 KRW | 6.61% |
| 2017 Q4 | 21.22 KRW | 121.16% |
| 2017 Q1 | -47.04 KRW | 79.03% |
| 2016 Q1 | -70.99 KRW | 32.17% |
| 2016 FY | - KRW | 28.23% |
| 2016 Q4 | -224.32 KRW | -250.99% |
| 2016 Q3 | -63.91 KRW | 21.74% |
| 2016 Q2 | -81.66 KRW | -15.03% |
| 2015 Q4 | -104.66 KRW | 22.09% |
| 2015 Q3 | -134.34 KRW | 13.18% |
| 2015 FY | - KRW | 17.53% |
| 2015 Q1 | -166.99 KRW | 62.11% |
| 2015 Q2 | -154.74 KRW | 7.34% |
| 2014 Q1 | -101.78 KRW | 92.57% |
| 2014 FY | - KRW | 80.44% |
| 2014 Q4 | -440.72 KRW | -396.08% |
| 2014 Q3 | -88.84 KRW | 10.6% |
| 2014 Q2 | -99.37 KRW | 2.37% |
| 2013 Q1 | -71.42 KRW | -3.07% |
| 2013 Q3 | -901.54 KRW | -20.17% |
| 2013 FY | - KRW | -587.95% |
| 2013 Q2 | -750.19 KRW | -950.39% |
| 2013 Q4 | -1370.38 KRW | -52.0% |
| 2012 FY | - KRW | 69.6% |
| 2012 Q2 | -282.97 KRW | -99.85% |
| 2012 Q1 | -141.59 KRW | 82.94% |
| 2012 Q4 | -69.29 KRW | -16.98% |
| 2012 Q3 | -59.23 KRW | 79.07% |
| 2011 Q2 | -703.74 KRW | -701.53% |
| 2011 Q4 | -829.90 KRW | -248.77% |
| 2011 FY | - KRW | -333.34% |
| 2011 Q1 | -87.80 KRW | 59.16% |
| 2011 Q3 | -237.95 KRW | 66.19% |
| 2010 Q3 | -236.90 KRW | 5.26% |
| 2010 Q2 | -250.06 KRW | -179.17% |
| 2010 Q1 | 315.87 KRW | 0.0% |
| 2010 FY | - KRW | -887.58% |
| 2010 Q4 | -214.98 KRW | 9.25% |
| 2009 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Daewoong Co., Ltd. | 3691.68 KRW | 103.738% |
| PharmGen Science, Inc. | 351.99 KRW | 139.206% |